Utah Medical Products, Inc. (UTMD)

NASDAQ • Healthcare

$74.23

-$0.82 (-1.1%)

Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$75.13

Day Range$74.04 - $75.13

Avg. Volume (3M)38.5K

Market Cap$235.5M

P/E Ratio22.2

52 Week Range

$53.66$76.89

Metrics Over Time

Where the Money Goes

Q3 2026

Revenueeverything earned$8.6M100%

Gross Profitminus cost of goods$4.8M56%

Operating Incomeminus R&D and overhead$2.7M32%

Net Incomeminus taxes and the rest$2.7M32%

In plain terms: out of every $100 in revenue, Utah Medical Products, Inc. keeps $32 as net profit.

Fundamentals & Financials

Revenue (TTM)

$34.9M

Net Income (TTM)

$10.6M

EPS (TTM)

$3.34

ROA (TTM)

8.28%

Current Ratio

21.23

Dividend Yield

0.42%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

$0.82Q4 2025

$0.8Q1 2026

$0.82Q2 2026

$0.84Q3 2026

$0.88Q4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026

Utah Medical Products’ preliminary results showed revenue falling year over year even as earnings rose in the third fiscal quarter of 2026, reported October 22, 2026. Revenue declined 12.1% to about $8.6 million (down from about $9.8 million a year ago), while EPS came in at $0.88, up from $0.82 a year ago. Profitability held at elevated levels, with gross margin at roughly 56% and operating margin near 32%, as gross profit was about $4.8 million and operating income was roughly $2.8 million. Net income increased 5.9% to about $2.8 million, up from roughly $2.6 million a year ago.

View full earnings history

About Utah Medical Products, Inc.

Utah Medical Products, Inc. makes specialty devices and disposables for hospital and clinical care, operating in the medical instruments and supplies business under the NASDAQ ticker UTMD. Its products span obstetrics, neonatal and critical-care tubing and monitoring items, and gynecologic surgery tools, and it generated $38.5 million in FY2025 revenue.

Name

Utah Medical Products, Inc.

CEO

Kevin L. Cornwell

Website

www.utahmed.com

Industry

Healthcare

Year Founded

1978

Employees

146

Today's Snapshot

AI-generated

The day ended with UTMD 1.1% lower at 74.23, in line with a weaker sector. UTMD closed within 3.5% of its 52-week high of 76.89. Utah Medical Products beat third-quarter earnings estimates by 87 cents per share.

Trading Volume

Below 10d avg (41.5K)

38.9K

vs S&P 500 Today

Underperforming Market

-0.59%

Updated: October 23, 2026 at 20:27 UTC

Technical Indicators

3 Buy3 Neutral2 Sell

UTMD presents a neutral technical picture with price near $74.23 caught between short‑term averages that are slightly bearish and medium/longer‑term averages that remain constructive, producing offsetting signals. Momentum indicators are muted—RSI around the middle and MACD slightly positive—while ADX suggests the market lacks directional conviction. Volume (OBV) is modestly positive and ATR implies low intraday volatility near $1.00, so price action has been contained. The pivot is a touch above current levels, giving a small ceiling to monitor. Technical takeaway: Neutral — balanced near‑term signals with no clear trend.

All signals

EMA (5 indicators)$67.49 - $74.60
Buy
RSI (14)51.19
Neutral
Stochastic %K (14, 3, 3)50.98
Neutral
MACD Level (12, 26)0.45
Neutral

Peers & Related Assets

OSUROraSure Technologies, Inc.

$4.13+8.7%

CATXPerspective Therapeutics, Inc.

$1.61-28.8%

CHRSCoherus Oncology, Inc.

$1.01-3.8%

PREPrenetics Global Limited

INFUInfuSystem Holdings, Inc.

PLXProtalix BioTherapeutics, Inc.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.